Stimulation of free radical formation by aminoglycoside antibiotics

Hearing Research

Volumn 128, Issue 1-2, 1999, Pages 112-118

  Sha, Su Hua ^a   Schacht, Jochen ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Epstein Barr virus cell; Gentamicin; Kanamycin; Neomycin; Neutrophil; Ototoxicity; Reactive oxygen species; Streptomycin

Indexed keywords

2,3 DIHYDROXYBENZOIC ACID; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ARACHIDONIC ACID; DEFEROXAMINE; FREE RADICAL; GENTAMICIN; HYPOXANTHINE; IRON CHELATING AGENT; KANAMYCIN; LUCIGENIN; LUMINOL; NEOMYCIN; PHENAZINE METHOSULFATE; PHORBOL 13 ACETATE 12 MYRISTATE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SODIUM SULFATE; STREPTOMYCIN; SUPEROXIDE; XANTHINE OXIDASE;

ANIMAL CELL; ARTICLE; CELL FREE SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GUINEA PIG; LUMINESCENCE; LYMPHOBLASTOID CELL; NEUTROPHIL; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; RESPIRATORY BURST; VIRUS CELL TRANSFORMATION;

ACRIDINES; ANIMALS; ANTI-BACTERIAL AGENTS; CELL AGING; CELL-FREE SYSTEM; CHEMILUMINESCENT MEASUREMENTS; GENTAMICINS; GUINEA PIGS; HERPESVIRUS 4, HUMAN; INDICATORS AND REAGENTS; IRON CHELATING AGENTS; LUMINOL; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; NEUTROPHILS; REACTIVE OXYGEN SPECIES;

EID: 0032961615     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5955(98)00200-7     Document Type: Article

References (40)

1. Bock G.R., Yates G.K., Miller J.J., Moorjani P. Effects of N-acetylcysteine on kanamycin ototoxicity in the guinea pig. Hear. Res. 9:1983;255-262.
2. Chanock S.J., El Benna J., Smith R.M., Babior B.M. The respiratory burst oxidase. J. Biol. Chem. 269:1994;24519-24522.
3. Clerici W.J., Hensley K., DiMartino D.L., Butterfield D.A. Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants. Hear. Res. 98:1996;116-124.
4. Conlon B.J., Smith D.W. Attenuation of neomycin ototoxicity by iron chelation. Laryngoscope. 108:1998;284-287.
5. Crann S.A., Huang M.Y., McLaren J.D., Schacht J. Formation of a toxic metabolite from gentamicin by a hepatic cytosolic fraction. Biochem. Pharmacol. 43:1992;1835-1839.
6. Dulon D., Aran J.-M., Zajic G., Schacht J. Comparative pharmacokinetics of gentamicin, netilmicin and amikacin in the cochlea and the vestibule of the guinea pig. Antimicrob. Agents Chemother. 30:1986;96-100.
7. Fantone J.C., Ward P.A. Polymorphonuclear leukocyte-mediated cell and tissue injury: oxygen metabolites and their relations to human disease. Hum. Pathol. 16:1985;973-978.
8. Federspil, P., 1979. Antibiotikaschäden des Ohres. Barth, Leipzig, pp. 86-89.
9. Garetz S.L., Altschuler R.A., Schacht J. Attenuation of gentamicin ototoxicity by glutathione in the guinea pig in vivo. Hear. Res. 77:1994;81-87.
10. Garetz S.L., Rhee D.J., Schacht J. Sulfhydryl compounds and antioxidants inhibit cytotoxicity to outer hair cells of a gentamicin metabolite in vitro. Hear. Res. 77:1994;75-80.
11. Gutteridge J.M. A method for removal of trace iron contamination from biological buffers. FEBS Lett. 214:1987;362-364.
12. Gyllenhammar H. Lucigenin chemiluminescence in the assessment of neutrophil superoxide production. J. Immunol. Methods. 97:1987;209-213.
13. Hennebert P.E. Traitement par le B.A.L. de l'intoxication labyrynthique par la streptomycine. Ann. Oto-Laryngol. (Paris). 68:1951;507-508.
14. Hirose K., Hockenberry D.N., Rubel E.W. Reactive oxygen species in chick hair cells after gentamicin exposure in vitro. Hear. Res. 104:1997;1-14.
15. Huang M.Y., Schacht J. Formation of a cytotoxic metabolite from gentamicin by liver. Biochem. Pharmacol. 40:1990;R11-R14.
16. Keller H., Krüpe W., Sous H., Mückter H. Versuche zur Toxizitätsminderung basischer Streptomyces-Antibiotika. 3. Mitteilung: Zum Mechanismus der Streptomycin-Vergiftung und ihre Beeinflußbarkeit durch Pantothensäure. Arzneim.-Forsch. 6:1956;379-384.
17. Li Y., Zhu H., Kuppusamy P., Roubaud V., Zweier J.L., Trush M.A. Validation of lucigenin (bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems. J. Biol. Chem. 273:1998;2015-2023.
18. Liochev S.I., Fridovich I. Lucigenin (bis-N-methylacridinium) as a mediator of superoxide anion production. Arch. Biochem. Biophys. 337:1997;115-120.
19. Lodhi S., Weiner N.D., Mechigian I., Schacht J. Ototoxicity of aminoglycosides correlated with their action on monomolecular films of polyphosphoinositides. Biochem. Pharmacol. 29:1980;597-601.
20. Nakajima T., Hishida A., Kato A. Mechanisms for protective effects of free radical scavengers on gentamicin-mediated nephropathy in rats. Am. J. Physiol. 266:1994;F425-F431.
21. Pierson M.G., Møller A.R. Prophylaxis of kanamycin-induced ototoxicity by a radioprotectant. Hear. Res. 4:1981;79-87.
22. Porter C.D., Parkar M.H., Collins M.K., Levinsky R.J., Kinnon C. Superoxide production by normal and chronic granulomatous disease (CGD) patient-derived EBV-transformed B cell lines measured by chemiluminescence-based assays. J. Immunol. Methods. 155:1992;151-157.
23. Prezant T.R., Shohat M., Jaber L., Pressman S., Fischel-Ghodsian N. Biochemical characterization of a pedigree with mitochondrially inherited deafness. Am. J. Med. Genet. 44:1992;465-472.
24. Priuska E.M., Schacht J. Formation of free radicals by gentamicin and iron and evidence for an iron/gentamicin complex. Biochem. Pharmacol. 50:1995;1749-1752.
25. Priuska E.M., Clark K., Pecoraro V., Schacht J. NMR spectra of iron-gentamicin complexes and the implications for aminoglycoside toxicity. Inorg. Chim. Acta. 273:1998;85-91.
26. Ramsammy L.S., Josepovitz C., Ling K.-Y., Lane B.P., Kaloyanides G.J. Failure of inhibition of lipid peroxidation by vitamin E to protect against gentamicin nephrotoxicity in the rat. Biochem. Pharmacol. 36:1987;2125-2132.
27. Rao U.M. Source of superoxide anion radical in aerobic mixtures consisting of NAD[P]H, 5-methylphenazinium methyl sulfate and nitroblue tetrazolium chloride. Free Radical Biol. Med. 7:1989;513-519.
28. Schacht J. Isolation of an aminoglycoside receptor from guinea pig inner ear tissues and kidney. Arch. Otorhinolaryngol. 224:1979;129-134.
29. Sha, S.-H., Schacht, J., 1998. Formation of reactive oxygen species following bioactivation of gentamicin. Free Radical Biol. Med. (in press).
30. Song B.-B., Schacht J. Variable efficacy of radical scavengers and iron chelators to attenuate gentamicin ototoxicity in guinea pig in vivo. Hear. Res. 94:1996;87-93.
31. Song B.-B., Anderson D.J., Schacht J. Protection from gentamicin ototoxicity by iron chelators in guinea pig in vivo. J. Pharmacol. Exp. Ther. 282:1997;369-377.
32. Song B.-B., Sha S.-H., Schacht J. Iron chelators protect from aminoglycoside-induced cochleo- and vestibulotoxicity in guinea pig. Free Radical Biol. Med. 25:1998;189-195.
33. Stratta P., Segoloni G.P., Canavese C., Muzio G., Dogliani M., Serra A., Allemandi P., Salomone M., Caramellino C., Canuto R. Oxygen free radicals are not the main factor in experimental gentamicin nephrotoxicity. Renal Fail. 16:1994;445-455.
34. Tran Ba Huy P., Bernard P., Schacht J. Kinetics of gentamicin uptake and release in the rat: Comparison of inner ear tissues and fluids with other organs. J. Clin. Invest. 77:1986;1492-1500.
35. Walker P.D., Shah S.V. Gentamicin-enhanced production of hydrogen peroxide by renal cortical mitochondria. Am. J. Physiol. 253:1987;C495-C499.
36. Walker P.D., Shah S.V. Evidence suggesting a role for hydroxyl radical in gentamicin-induced acute renal failure in rats. J. Clin. Invest. 81:1988;334-341.
37. Wang B.M., Weiner N.D., Takada A., Schacht J. Characterization of aminoglycoside-lipid interactions and development of a refined model for ototoxicity testing. Biochem. Pharmacol. 33:1984;3257-3262.
38. Ward P.A., Till G.O., Kunkel R., Beauchamp C. Evidence for role of hydroxyl radical in complement and neutrophil-dependent tissue injury. J. Clin. Invest. 72:1983;789-801.
39. 2 produced by human neutrophils during the respiratory burst. Anal. Biochem. 165:1987;371-378.
40. Yang C.L., Du X.H., Han Y.X. Renal cortical mitochondria are the source of oxygen free radicals enhanced by gentamicin. Renal Fail. 17:1995;21-26.